GenMark Diagnostics, Inc. announced the appointment of Lisa Giles, President and CEO of Giles & Associates Consultancy, and Michael Kagnoff, a partner at DLA Piper (US), to its board of directors. At the same time Steve Worland has resigned from the Board. Ms. Giles has been the President and CEO of Giles & Associates Consultancy since 2000, and CEO of Optivara, Inc. since 2013.

Mr. Kagnoff has served as a partner at DLA Piper (US) since April 2008. Prior to joining DLA Piper, he was a stockholder at Heller Ehrman LLP. He has provided legal and business advice on a range of topics, including strategic transactions, corporate governance, and compensation matters.

The appointments of Ms. Giles and Mr. Kagnoff were effective February 19, 2015. Each was appointed as a Class III director, with a term of office expiring at the company's 2016 annual meeting of shareholders. With their addition to the Board, Giles will become a member of the Audit Committee and Kagnoff will become a member of the Corporate Governance and Nominating Committee.